These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 13832708)
1. Penetration of brain and brain tumor by aromatic compounds as a function of molecular substituents. SOLOWAY AH; WHITMAN B; MESSER JR J Pharmacol Exp Ther; 1960 Jul; 129():310-4. PubMed ID: 13832708 [No Abstract] [Full Text] [Related]
2. PENETRATION OF BRAIN AND BRAIN TUMOR BY AROMATIC COMPOUNDS AS A FUNCTION OF MOLECULAR SUBSTITUENTS. III. SOLOWAY AH; WHITMAN B; MESSER JR J Med Pharm Chem; 1962 Jan; 5():191-6. PubMed ID: 14046607 [No Abstract] [Full Text] [Related]
3. Correlation of drug penetration of brain and chemical structure. SOLOWAY AH Science; 1958 Dec; 128(3338):1572-4. PubMed ID: 13615310 [No Abstract] [Full Text] [Related]
4. [Pharmacological properties of certain aromatic boron derivatives]. JAKIMOWSKA K Acta Physiol Pol; 1960; 11():731. PubMed ID: 13789228 [No Abstract] [Full Text] [Related]
5. Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy. Chandra S; Kabalka GW; Lorey DR; Smith DR; Coderre JA Clin Cancer Res; 2002 Aug; 8(8):2675-83. PubMed ID: 12171900 [TBL] [Abstract][Full Text] [Related]
6. Quantitative imaging of a radiotherapeutic drug, Na2B12H11SH, at subcellular resolution in tissue cultures using ion microscopy. Zha X; Ausserer WA; Morrison GH Cancer Res; 1992 Oct; 52(19):5219-22. PubMed ID: 1394124 [TBL] [Abstract][Full Text] [Related]
7. [Influence of boron ions on the membrane potential of single cardiac fibers]. MEDA E; FERRONI A Boll Soc Ital Biol Sper; 1961 Feb; 37():143-5. PubMed ID: 13768816 [No Abstract] [Full Text] [Related]
8. N(4)-[B-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan)methyl]-2'-deoxycytidine as a potential boron delivery agent with respect to glioblastoma. Uram Ł; Nizioł J; Maj P; Sobich J; Rode W; Ruman T Biomed Pharmacother; 2017 Nov; 95():749-755. PubMed ID: 28888921 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of boron compounds for use in neutron capture therapy of brain tumors. I. Animal investigations. SOLOWAY AH; WRIGHT RL; MESSER JR J Pharmacol Exp Ther; 1961 Oct; 134():117-22. PubMed ID: 13915041 [No Abstract] [Full Text] [Related]
10. Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study. Matsumura A; Zhang T; Nakai K; Endo K; Kumada H; Yamamoto T; Yoshida F; Sakurai Y; Yamamoto K; Nose T J Exp Clin Cancer Res; 2005 Mar; 24(1):93-8. PubMed ID: 15943038 [TBL] [Abstract][Full Text] [Related]
11. Boron as a platform for new drug design. Ciani L; Ristori S Expert Opin Drug Discov; 2012 Nov; 7(11):1017-27. PubMed ID: 22946655 [TBL] [Abstract][Full Text] [Related]
12. Boron self-shielding effects on dose delivery of neutron capture therapy using epithermal beam and boronophenylalanine. Ye SJ Med Phys; 1999 Nov; 26(11):2488-93. PubMed ID: 10587238 [TBL] [Abstract][Full Text] [Related]
13. Boron and its compounds: current biological research activities. Bolt HM; Duydu Y; Başaran N; Golka K Arch Toxicol; 2017 Aug; 91(8):2719-2722. PubMed ID: 28601966 [No Abstract] [Full Text] [Related]
14. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600 [TBL] [Abstract][Full Text] [Related]
15. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry. Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510 [TBL] [Abstract][Full Text] [Related]
16. A novel nutritional supplement containing chromium picolinate, phosphatidylserine, docosahexaenoic acid, and boron activates the antioxidant pathway Nrf2/HO-1 and protects the brain against oxidative stress in high-fat-fed rats. Sahin N; Akdemir F; Orhan C; Aslan A; Agca CA; Gencoglu H; Ulas M; Tuzcu M; Viyaja J; Komorowskı JR; Sahin K Nutr Neurosci; 2012 Sep; 15(5):42-7. PubMed ID: 23232054 [TBL] [Abstract][Full Text] [Related]
17. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. Ceberg CP; Brun A; Kahl SB; Koo MS; Persson BR; Salford LG J Neurosurg; 1995 Jul; 83(1):86-92. PubMed ID: 7782856 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration. Pettersson OA; Carlsson J; Grusell E Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968 [TBL] [Abstract][Full Text] [Related]
19. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma. Morris GM; Micca PL; Coderre JA Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168 [TBL] [Abstract][Full Text] [Related]
20. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]